Loading clinical trials...

Treatment of Postoperative Pain After Total Hip Arthroplasty Using Intravenous Lidocaine Infusion | Clinical Trials | Clareo Health

Back to clinical trial search

WITHDRAWNPhase 1/2NCT01108562

Treatment of Postoperative Pain After Total Hip Arthroplasty Using Intravenous Lidocaine Infusion

This study will focus on patients undergoing total hip arthroplasty and Loma Linda University Medical Center \& East Campus. These patients will be randomized to receive a low dose lidocaine infusion ...

Lead sponsor: Loma Linda University•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

Not Yet RecruitingNA

MRI-Based Assessment of Local Anesthetic Spread in the PENG Block Compartment

NCT07040423 · Total Hip Arthroplasty (THA), Postoperative Pain Management After Total Hip Arthroplasty

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 6, 2015Terms

Trial snapshot

StatusWITHDRAWN

PhasePHASE1/PHASE2

Enrollment—

Start dateFeb 2008

Last updatedApr 6, 2015

Condition

Postoperative Pain Management After Total Hip Arthroplasty

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 6, 2015Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions